Aquestive Therapeutics, Inc. - Common Stock, Par Value $0.001 Per Share (AQST)

CUSIP: 03843E104

Q1 2019 13F Holders as of 31 Mar 2019

Holder snapshot 6 signals
Share change
+46,735
SEC-reported price per share
$6.91
Indexed holders
49
Value change
+$442,125
Number of buys
32
Number of sells
14
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
125,140,813

Security key

03843E104

Report period

Q1 2019

Indexed institutions

49

Top holders

10

Ownership snapshot

Top reported holders of AQST - Aquestive Therapeutics, Inc. - Common Stock, Par Value $0.001 Per Share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Bratton Capital Managemen...
Disclosed value leader
Bratton Capital Managemen...
Comparable rows
0/15
Latest evidence
31 Dec 2018
13F Highest disclosed value: $72,471,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Bratton Capital Management, L.P. has the largest disclosed position value at $72.47M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bratton Capital Management, L.P.'s linked filing trail.
Disclosed position value Top 5
Bratton Capital Management, L.P. $72.47M
ALLIANCEBERNSTEIN L.P. $4.1M
BlackRock Finance, Inc. $4.04M
MASSACHUSETTS FINANCIAL SERVICES ... $2.99M
VANGUARD GROUP INC $2.14M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Bratton Capital Management, L.P.
13F
Company
13F
—
denominator unverified
$72,471,000
11,503,294 shares
— 31 Dec 2018
ALLIANCEBERNSTEIN L.P.
13F
Company
13F
—
denominator unverified
$4,103,000
651,215 shares
— 31 Dec 2018
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$4,042,000
641,800 shares
— 31 Dec 2018
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
13F
—
denominator unverified
$2,986,000
473,930 shares
— 31 Dec 2018
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$2,139,000
339,448 shares
— 31 Dec 2018
WASATCH ADVISORS LP
13F
Company
13F
—
denominator unverified
$916,000
145,373 shares
— 31 Dec 2018
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
49
Shares
14,418,719
Indexed holders
49
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2019 vs Q4 2018 Across Filers

Q4 2018 indexed holders
35
Q1 2019 indexed holders
49
Indexed holder difference
14
Investor Q4 2018 Shares Q1 2019 Shares Share Diff Share Chg % Q4 2018 value Q1 2019 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .